World-First Human Trial Could See Lymph Nodes Turned Into Livers

After more than a decade of development, the first human trial for a treatment that attempts to tackle end-stage liver disease (ESLD) by turning lymph nodes into livers has begun. “In a medical first, we have now dosed our first patient in a clinical trial using their own lymph nodes as living bioreactors to regenerate an ectopic organ," said Dr Michael Hufford, co-founder and CEO of LyGenesis – the company behind the treatment – in a statement. The treatment works …